Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The study also assessed safety outcomes
What the Research Shows About Tirzepatide Blood Pressure Effects Clinical studies using both standard office measurements and ambulatory blood pressure monitoring have found that tirzepatide is associated with: Lower average systolic blood pressure Smaller but consistent reductions in diastolic pressure Improvements that become more noticeable over several months On average, systolic blood pressure reductions tend to fall within the midsingle-digit mmHg range, which can be clinically meaningful, particularly for people with obesity-related hypertension
The long half-life of tirzepatide means therapeutic levels persist for days after each injection, providing a buffer against single missed doses
Biomed Khim
2022 NEJM) showed tirzepatide at 15 mg produced average weight loss of 20.9% over 72 weeks in adults with obesity
Semiglutide mimics the actions of a hormone known as GLP-1, or glucagon-like peptide-1
US$ 26.65
US$ 27.26
US$ 21.48
US$ 20.55
